Clinical Trials
3 trialsNCT00069238 2022-02-24
Campath-1H and EPOCH to Treat Non-Hodgkin's T- and NK-Cell Lymphomas
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00646854 2019-03-01
ACT-1
University of Aarhus
Phase 3 Completed
NCT00161590 2008-10-22
Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma
Weill Medical College of Cornell University
Phase 1 Completed